Literature DB >> 20040395

Fibrocytes are involved in the pathogenesis of human chronic kidney disease.

Norihiko Sakai1, Kengo Furuichi, Yasuyuki Shinozaki, Hiroyuki Yamauchi, Tadashi Toyama, Shinji Kitajima, Toshiya Okumura, Satoshi Kokubo, Motoo Kobayashi, Kazuya Takasawa, Shin-ichi Takeda, Mitsuhiro Yoshimura, Shuichi Kaneko, Takashi Wada.   

Abstract

The presence of chronic kidney disease in humans is associated with a risk of kidney function loss as well as the development of cardiovascular disease. Fibrocytes have been shown to contribute to organ fibrosis. In this study, the presence of fibrocytes was investigated immunohistochemically in kidney biopsy specimens from 100 patients with chronic kidney disease. In addition, 6 patients with thin basement membrane disease were studied as a disease control. In patients with chronic kidney disease, the infiltration of fibrocytes was observed mainly in the interstitium. The number of interstitial fibrocytes in patients with chronic kidney disease was higher than that in patients with thin basement membrane disease. The number of infiltrated fibrocytes in the interstitium correlated well with the severity of tubulointerstitial lesions, such as interstitial fibrosis, in patients with chronic kidney disease. In addition, there were significant correlations between the number of interstitial fibrocytes and the number of CD68-positive macrophages in the interstitium as well as urinary monocyte chemoattractant protein-1/CCL2 levels. In particular, there was an inverse correlation between the number of interstitial fibrocytes and kidney function at the time of biopsy. Finally, the numbers of interstitial fibrocytes and macrophages as well as urinary CCL2 levels were significantly decreased during convalescence induced by glucocorticoid therapy. These results suggest that fibrocytes may be involved in the pathogenesis of chronic kidney disease through the interaction with macrophages as well as CCL2. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20040395     DOI: 10.1016/j.humpath.2009.10.008

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  23 in total

1.  Inhibition of murine fibrocyte differentiation by cross-linked IgG is dependent on FcγRI.

Authors:  Darrell Pilling; Jeffrey R Crawford; J Sjef Verbeek; Richard H Gomer
Journal:  J Leukoc Biol       Date:  2014-04-21       Impact factor: 4.962

Review 2.  Renal interstitial fibrosis: mechanisms and evaluation.

Authors:  Alton B Farris; Robert B Colvin
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-05       Impact factor: 2.894

3.  IL-17A/F modulates fibrocyte functions in cooperation with CD40-mediated signaling.

Authors:  Hisako Hayashi; Akiko Kawakita; Shintaro Okazaki; Motoko Yasutomi; Hiroki Murai; Yusei Ohshima
Journal:  Inflammation       Date:  2013-08       Impact factor: 4.092

4.  TNF-α-stimulated fibroblasts secrete lumican to promote fibrocyte differentiation.

Authors:  Darrell Pilling; Varsha Vakil; Nehemiah Cox; Richard H Gomer
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-08       Impact factor: 11.205

Review 5.  Renal fibrosis: novel insights into mechanisms and therapeutic targets.

Authors:  Peter Boor; Tammo Ostendorf; Jürgen Floege
Journal:  Nat Rev Nephrol       Date:  2010-09-14       Impact factor: 28.314

Review 6.  Involvement of bone-marrow-derived cells in kidney fibrosis.

Authors:  Takashi Wada; Norihiko Sakai; Yoshio Sakai; Kouji Matsushima; Shuichi Kaneko; Kengo Furuichi
Journal:  Clin Exp Nephrol       Date:  2010-12-10       Impact factor: 2.801

Review 7.  Contribution of bone marrow-derived fibrocytes to liver fibrosis.

Authors:  Jun Xu; Min Cong; Tae Jun Park; David Scholten; David A Brenner; Tatiana Kisseleva
Journal:  Hepatobiliary Surg Nutr       Date:  2015-02       Impact factor: 7.293

8.  Fibroblasts secrete Slit2 to inhibit fibrocyte differentiation and fibrosis.

Authors:  Darrell Pilling; Zhichao Zheng; Varsha Vakil; Richard H Gomer
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-08       Impact factor: 11.205

Review 9.  Nodular lesions and mesangiolysis in diabetic nephropathy.

Authors:  Takashi Wada; Miho Shimizu; Hitoshi Yokoyama; Yasunori Iwata; Yoshio Sakai; Shuichi Kaneko; Kengo Furuichi
Journal:  Clin Exp Nephrol       Date:  2012-10-26       Impact factor: 2.801

10.  CCL2/CCR2 augments the production of transforming growth factor-beta1, type 1 collagen and CCL2 by human CD45-/collagen 1-positive cells under high glucose concentrations.

Authors:  Akinori Hara; Norihiko Sakai; Kengo Furuichi; Yoshio Sakai; Motohiro Takeya; Richard Bucala; Naofumi Mukaida; Yoh Takuwa; Kouji Matsushima; Shuichi Kaneko; Takashi Wada
Journal:  Clin Exp Nephrol       Date:  2013-04-06       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.